Evaluation of Diuretic
Potential of Amritarishta Prepared by Traditional and
Modern Methods in Experimental Albino Rats
Preeti
Tiwari
Head of Department of Pharmacognosy, Dr.
K. N. Modi Institute of Pharmaceutical Education and
Research, Modinagar, Uttar Pradesh, India.
*Corresponding Author E-mail: preetitiwari198311@yahoo.com
ABSTRACT:
The objective of the present study was to evaluate the diuretic
potential of Amritarishta-T and Amritarishta-M
prepared by traditional and modern methods respectively and its marketed
formulation in experimental rats using furosemide (10
mg/kg p.o.) as a standard diuretic drug. Oral
administration of Amritarishta-T, Amritarishta-M
and its marketed formulation at the dose of 2.0 ml/kg over a period of 5 h
showed a significant increase in urine volume as compared to control group.
Both types of Amritarishta as Amritarishta-T
and Amritarishta-M prepared by traditional and modern
methods respectively and its marketed formulation showed significant increase
in sodium, potassium and chloride level in urine sample as compared to control
group. The maximum diuretic effect was produced by furosemide.
Thus, both types of Amritarishta as Amritarishta-T and Amritarishta-M
and its marketed formulation showed significant diuretic, natriuretic
and kaliuretic effects.
KEYWORDS: Diuretic
potential, furosemide, Amritarishta,
natriuretic effect, kaliuretic
effect.
1. INTRODUCTION:
Amritarishta is a polyherbal hydroalcoholic Ayurvedic
preparation and is used as antioxidant and advised as a choice of remedy in
mostly all types of fevers1. The chief ingredient of Amritarishta is guduchi, dried
stem of Tinospora cordifolia.
The chemical constituents reported from stems of Tinospora cordifolia belong to different classes
such as alkaloids as tinosporin2-3, glycosides as cordifoliosides-A and cordifolioside-B4-5,
steroids as β- sitosterol6, sesquiterpenoid
as tinocordifolin7 and a large amount of phenolic
compounds as gallic aciod, ellagic acid, catechin and epicatechin8. These compounds have
many notable medicinal properties as antidiabetic9, hepatoprotective10,
antioxidant11, antimalarial12, immunomodulatory13
and antineoplastic properties14.
However, no study has been carried out for the diuretic activity
of Amritarishta in order to confirm its assumed
beneficial property. Therefore, we have undertaken the present study to verify
the efficacy of all the test formulations of Amritarishta
as Amritarishta-T and Amritarishta-M
prepared by traditional and modern methods respectively and its marketed
formulation as diuretic agent in albino rats.
2. MATERIALS AND
METHODS:
2.1 Preparation of Amritarishta-T:
This was prepared by the method as given in The Ayurvedic Formulary of India, Part-I1. All the
ingredients of Amritarishta were procured from local
market, Jamnagar while jaggery was procured from
local market, Mehsana. Authentication of all the
ingredients of Amritarishta was done by Dr. G. D. Bagchi, Scientist, Department of Taxonomy and
Pharmacognosy, Central Institute of Medicinal and Aromatic Plants, Lucknow.
Prepared herbarium has been deposited in the Central Institute of Medicinal and
Aromatic Plants, Lucknow for future reference. Identification of all the
individual plant material was done as per The Ayurvedic
Pharmacopoeia of India. Quantity of ingredients taken for the preparation of
batch size 3.072 l of Amritarishta has been
calculated according to the formula as given in The Ayurvedic
Formulary of India, Part-I, 2000.
According to this method, coarsely powdered stems of guduchi (Tinospora cordifolia) with prescribed ingredients as Aegle marmelos
(stem bark), Oroxylum indicum (roots),
Gmelina arborea (stem
bark), Stereospermum suaveolns
(stem bark), Premna integrifolia
(stem bark), Hedysarum gangeticum (entire
plant), whole plant of Paederia foetida,
entire plant of Solanum indicum,
entire plant of Solanum xanthocarpum
and Tribulus terrestris
were placed in polished vessel of brass along with prescribed quantity of water
(12.288l) and allowed to steep. After 12 h of steeping, this material was
warmed at medium flame until the water for decoction reduced to one fourth of
the prescribed quantity(3.072 l) , then the heating was stopped and it was
filtered in cleaned vessel and after that jaggery was
added and mixed properly. Then, prakshepa dravyas as svet jiraka, raktapuspaka, saptaparni, sunthi, marica, pippali, nagakesara, mustaka, katuka, ativisa and indravaruni in fine powdered form were added and this sweet
filtered material was placed for fermentation in incubator for fifteen days at
33±1°C. After 15 days completion of fermentation was confirmed by standard
tests15. The fermented preparation was filtered with cotton cloth
and kept in clean covered vessel for further next seven days. Then, when the
fine suspended particles settled down, it is strained again and poured in amber
colored glass bottles previously rinsed with ethyl alcohol, packed and properly
labelled.
2.2 Preparation of Amritarishta-M:
Method of preparation of Amritarishta-M
was same as followed for Amritarishta-T only in
addition to jaggery, yeast was also added for inducing fermentation16.
2.3 Animals
Adult wistar albino rats, weighing
between 200-220g of either sex were acclimatized to normal environmental
conditions in the animal house for one week. The animals were housed in
standard polypropylene cages and maintained under controlled room temperature
(22ºC±2ºC) and humidity (55±5%) with 12:12 hour light and dark cycle. All the
animals were given a standard chow diet (Hindustan Lever Limited) and water ad libitum.
The guidelines of the Committee for the Purpose of Control and Supervision of Experimentals on Animals (CPCSEA) of the Government of
India were followed and prior permission was granted from the Institutional
Animals Ethics Committee (CPCSEA No. 07/09).
2.4. Experimental Procedure
The method of Lipschitz et al., (1943)
was employed for the assessment of diuretic activity. Twenty four hours before
testing the animals were transferred to metabolic cages17.Then only
water was made accessible ad libitum without food.
All the animals were randomly divided into the five groups with
six animals in each group as follows:
Group I : Control group received normal saline as
vehicle (25 ml/kg, p.o.)
Group II
: Animals received furosemide (10 mg/kg, p.o.)
Group III : Animals received Amritarishta-T
(2 ml/kg, p.o.)
Group IV : Animals received Amritarishta-M
(2 ml/kg, p.o.)
Group V : Animals received marketed Amritarishta
(2 ml/kg, p.o.)
The second group received same volume of normal saline (25 ml) in
which furosemide (10 mg/kg bw) was dissolved. The animals of Group III, IV and V
received Amritarishta-T, Amritarishta-M
and marketed Amritarishta at the dose of 2 ml/kg bw orally, after diluting to all of them up to 25 ml with
normal saline to maintain the fluid intake same in all the cases. Immediately
after dosing the rats were placed in metabolic cages and kept at room
temperature of 25 ºC±0.5 ºC for 5 h. During this period, no food and water was
made available to them. At the end of 5 h the animals were taken out of the
cages and the total volume of urine excreted by each group was noted. Urine
samples were analysed thereafter for Na+
and K+ concentration by flame photometer while chloride (Cl-) was determined by using standard kit
containing chloride reagent from span diagnostics, Surat,
India.
2.5. Statistical analysis
The results have been expressed as mean ± SEM. Statistical
analysis of data among the various groups was performed by using one way
analysis of variance (ANOVA) followed by the Tukey’s
test using Graph Pad Prism software of Statistics. Significance value (P<0.05) was considered statistically
significant.
3.
RESULTS:
Diuretic effect
Total urine output
Both types of Amritarishta as Amritarishta-T and Amritarishta-M
were prepared by traditional and modern methods respectively showed significant
(P<0.001) increase in urine
volume, as compared to control group. The diuresis
was almost equal to that produced by furosemide (Fig.1).
Urinary electrolyte
concentration
Urinary sodium: All the test formulations of Amritarishta
as Amritarishta-T, Amritarishta-M
and its marketed formulation were found to produce significant (P<0.001) increase in natriuresis but the maximum natriuresis
was produced by furosemide (Fig.2).
Urinary potassium:
Both types of Amritarishta as Amritarishta-T and Amritarishta-M
have been found to produce significant (P<0.001)
increase in the excretion of potassium in urine as compared to the control
group. Furosemide also significantly increased the
excretion of potassium. Thus, all the test formulations of Amritarishta
showed significant kaliuretic effect (Fig.2).
Urinary chloride:
All the test formulations of Amritarishta
as Amritarishta-T, Amritarishta-M
and its marketed formulation showed significant (P<0.001) increase in the excretion of chloride in urine as
compared to control. Furosemide also showed
significant increase in the excretion of chloride in urine (Fig.2).
b
Fig. 1. Effect of Amritarishta-T, M and
marketed Amritarishta on urine volume
All values are expressed as mean ± SEM (n = 6)
b P<0.001
as compared to contr

Fig. 2.
Effect of Amritarishta-T, M and marketed Amritarishta on urinary electrolyte concentration
All values are expressed as mean ± SEM (n = 6)
b P<0.001
as compared to control
b
4. DISCUSSION:
This study shows that both types of Amritarishta
as Amritarishta-T and Amritarishta-M
prepared by traditional and modern methods respectively and its marketed formulation
produced striking increase in total urine output over a period of 5 h. All
these test formulations of Amritarishta also showed
significant (P<0.001) increase in
the excretion of sodium, potassium and chloride in urine as compared to control
group. Therefore, both types of Amritarishta as Amritarishta-T and Amritarishta-M
have been shown to possess significant diuretic, natriuretic
and kaliuretic effects which may be one of the basis of their therapeutic application in various ailments,
such as nephritis, burning micturation etc. and
different oedematous diseases. Their diuretic effects
have been shown to be more or less equal to that produced by furosemide.
Preliminary phytochemical studies have
confirmed the presence of phenolics, particularly
hydrolysable tannins and flavonoids and other nonphenolic constituents as steroidal saponins
in all the test formulations of Amritarishta as Amritarishta-T, Amritarishta-M
and its marketed formulation, promoting the hypothesis that these type of polar compounds may also be responsible for the
diuretic effects. It is known that this type of compounds increase renal
circulation, and thus the rate of glomerular
filtration which promotes increased urine formation18-20. Thus,
presence of self generated alcohol helps in the faster absorption of
biologically active compounds as tannins, flavonoids
and steroidal saponins which by their chemical nature
are antioxidants, might contribute to the prevention of cardiac diseases as
hypertension by acting as diuretics21.
5.
REFERENCES:
1)
The Ayurvedic Formulary of India,
Part-I. 2000, 1st edition, The Controller of Publications, Delhi, 6.
2)
Kumar S, Verma NS, Pande D and Srivastava PS. In vitro regeneration and screening of berberinein
Tinospora cordifolia.
Journal of Medicinal and Aromatic Plant Science 2000;22:61.
3)
Biset NG and Nwaiwu J.Quaternary alkaloids of Tinospora species. Planta
Medica 1983;48:275-9.
4)
Maurya R, Wazir V, Tyagi A and Kapil RS. Cordifoliosides A and
B, two new phenylpropene disaccharides from Tinospora cordifolia
possessing immunostimulant activity. Natural Product
Letter 1996;8:7-10.
5)
Gangan VD, Pradhan P, Sipahimalani AT and Banerji A. Cordifoliosides A, B,C:Norditerpene furan glycosides from Tinospora cordifolia. Phytochemistry 1994;37:781-6.
6)
Dixit SN and Khosa RL. Chemical
investigation of Tinospora cordifolia.
Indian Journal of Applied Chemistry 1971;34:46-7.
7)
Maurya R and Handa SS. Tinocordifolin, a sesquiterpene from Tinospora cirdifolia. Phytochemistry 1998;49:1343-6.
8)
Kidwai AR, Salooja KC, Sharma VN, Siddiqui
S. Chemical examination of Tinospora cordifolia. Journal of Science and Indian Research
1949; 8:115-8.
9)
Stanely M, Prince P and Menon VP. Antioxidant action of Tinospora cordifolia root extract in alloxan diabetic rats.Phytotherapy
Research 2001;15:213-8.
10)
Mehrotra R, Katiyar CK and Gupta AP. Hepatoprotective
compositions and composition for treatment of conditions related to hepatitis-B
and E infection. US Patent 749296. 2000.
11)
Prince PS and Menon VP.
Antioxidant activity of Tinospora cordifolia roots in experimental
diabetes. Journal of Ethnopharmacology 1999;65:277-81.
12)
Ikram M, Khattak SG and Gilani SN.
Antipyretic studieson some indigenous Pakistani
medicinal plants. Journal of Ethnopharmacology 1987;19:185-92.
13)
Manjrekar PN, Jolly CI and
Narayanan S. Comparative studies of immunomodulatory
activity of Tinospora cordifolia
and Tinospora sinensis. Fitoterapia 2000;71:254-7.
14)
Jagetia GC, Nayak V and Vidyasagar MS.
Evaluation of the antineoplastic activity of guduchi (Tinospora cordifolia) in cultured HeLa
cells. Cancer Letter 1998;127:71-82.
15)
Mishra S. Bhaisazya Kalpana Vigyan. Varanasi, India: Chaukambha
Surbharati Prakashan;
2005.p. 253-254.
16)
Alam M, Radhamani
S, Ali U and Purushottam KK. Microbiological
Screening of Dhataki flowers. Journal of Research in Ayurveda and Siddha 1984;
2(4):371-375.
17)
Lipschitz
WL, Hadidian Z, Kerpcsar A.
Bioassay of Diuretics. Journal of Pharmacology and Experimental Therapeutics
1943; 79:97-110.
18)
Afzal
M, Khan NA, Ghufran A, Iqbal
A, Inamuddin M. Diuretic and nephroprotective
effect of Jawarish Zarooni Sada- a polyherbal Unani formulation. Journal of Ethnopharmacology
2004;91:219-223.
19)
Loew D, Heimsoth
V, Erwin K, Schilcher H. 1991. Diureticos:
Quimica, Farmacologiay Therapeutica incluida Fitoterapia, Barcelona, Salvat Editores S.A.:270.
20)
Das PK, Goswami S, Chinniah A. Woodfordia fruticosa:
Traditional uses and recent findings. Journal of Ethnopharmacology
2007; 110:189-199.
21)
Hollman PCH, Katan MB. Dietary Flavonoids:
Intake, Health effects and bioavailability. Food and Chemical Toxicology 1999;
37:937-942.
Received on 26.11.2013 Accepted on 22.12.2013
© Asian Pharma
Press All Right Reserved
Asian J. Res.
Pharm. Sci. 2013; Vol. 3: Issue 4, Pg
229-232